AIMC Topic: Cardiovascular Diseases

Clear Filters Showing 191 to 200 of 736 articles

Multimodal AI/ML for discovering novel biomarkers and predicting disease using multi-omics profiles of patients with cardiovascular diseases.

Scientific reports
Cardiovascular diseases (CVDs) are complex, multifactorial conditions that require personalized assessment and treatment. Advancements in multi-omics technologies, namely RNA sequencing and whole-genome sequencing, have provided translational researc...

ChatGPT Responses to Clinical Questions in the Japan Atherosclerosis Society Guidelines for Prevention of Atherosclerotic Cardiovascular Disease 2022.

Journal of atherosclerosis and thrombosis
AIMS: Artificial intelligence is increasingly used in the medical field. We assessed the accuracy and reproducibility of responses by ChatGPT to clinical questions (CQs) in the Japan Atherosclerosis Society Guidelines for Prevention Atherosclerotic C...

Artificial Intelligence Algorithms in Cardiovascular Medicine: An Attainable Promise to Improve Patient Outcomes or an Inaccessible Investment?

Current cardiology reports
PURPOSE OF REVIEW: This opinion paper highlights the advancements in artificial intelligence (AI) technology for cardiovascular disease (CVD), presents best practices and transformative impacts, and addresses current concerns that must be resolved fo...

Identifying cardiovascular disease risk in the U.S. population using environmental volatile organic compounds exposure: A machine learning predictive model based on the SHAP methodology.

Ecotoxicology and environmental safety
BACKGROUND: Cardiovascular disease (CVD) remains a leading cause of mortality globally. Environmental pollutants, specifically volatile organic compounds (VOCs), have been identified as significant risk factors. This study aims to develop a machine l...

Development and validation of a cardiovascular risk prediction model for Sri Lankans using machine learning.

PloS one
INTRODUCTION AND OBJECTIVES: Sri Lankans do not have a specific cardiovascular (CV) risk prediction model and therefore, World Health Organization(WHO) risk charts developed for the Southeast Asia Region are being used. We aimed to develop a CV risk ...

Enhancing cross-domain robustness in phonocardiogram signal classification using domain-invariant preprocessing and transfer learning.

Computer methods and programs in biomedicine
BACKGROUND AND OBJECTIVE: Phonocardiogram (PCG) signal analysis is a non-invasive and cost-efficient approach for diagnosing cardiovascular diseases. Existing PCG-based approaches employ signal processing and machine learning (ML) for automatic disea...

Empirical investigation of multi-source cross-validation in clinical ECG classification.

Computers in biology and medicine
Traditionally, machine learning-based clinical prediction models have been trained and evaluated on patient data from a single source, such as a hospital. Cross-validation methods can be used to estimate the accuracy of such models on new patients or...

Machine learning-based risk prediction for major adverse cardiovascular events in a Brazilian hospital: Development, external validation, and interpretability.

PloS one
BACKGROUND: Studies of cardiovascular disease risk prediction by machine learning algorithms often do not assess their ability to generalize to other populations and few of them include an analysis of the interpretability of individual predictions. T...

Bootstrap each lead's latent: A novel method for self-supervised learning of multilead electrocardiograms.

Computer methods and programs in biomedicine
BACKGROUND AND OBJECTIVE: Electrocardiogram (ECG) is one of the most important diagnostic tools for cardiovascular diseases (CVDs). Recent studies show that deep learning models can be trained using labeled ECGs to achieve automatic detection of CVDs...

Application of a deep-learning marker for morbidity and mortality prediction derived from retinal photographs: a cohort development and validation study.

The lancet. Healthy longevity
BACKGROUND: Biological ageing markers are useful to risk stratify morbidity and mortality more precisely than chronological age. In this study, we aimed to develop a novel deep-learning-based biological ageing marker (referred to as RetiPhenoAge here...